This decision is highly personal and should be made in partnership with a qualified bariatric care team that considers: Medical history Insurance eligibility Weight loss goals Long-term health outcomes What Patients in California Should Consider Next If you are currently usingor consideringGLP-1 medications and are concerned about insurance coverage, cost, or long-term sustainability, it may be time to explore all evidence-based weight loss options
When a drug is listed as "currently in shortage," compounding pharmacies can produce copies under Section 503A without violating the FDA's prohibition on compounding copies of commercially available drugs
Yerba mate is unlikely to cause harm to healthy adults who drink it occasionally
Accessed November 28, 2025
Its best to discuss options with your healthcare provider to determine which weight-loss drug is more appropriate for you
The glucagon component may partially offset constipation through its own gastrointestinal effects, but published data is still limited